Cargando…

FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors

Detalles Bibliográficos
Autores principales:	Carracedo, Alma, Egervari, Kristof, Salido, Marta, Rojo, Federico, Corominas, Josep M, Arumi, Montserrat, Corzo, Cristina, Tusquets, Ignacio, Espinet, Blanca, Rovira, Ana, Albanell, Joan, Szollosi, Zoltan, Serrano, Sergi, Solé, Francesc
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688943/ https://www.ncbi.nlm.nih.gov/pubmed/19439036 http://dx.doi.org/10.1186/bcr2239

Ejemplares similares

Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry
por: Salido, Marta, et al.
Publicado: (2005)

MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)
por: Casadevall, David, et al.
Publicado: (2015)

MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines
por: Arriola, E, et al.
Publicado: (2011)

Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy
por: Muntasell, Aura, et al.
Publicado: (2017)

Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-κB target genes in human breast cancer
por: Dalmases, Alba, et al.
Publicado: (2013)

Biomarkers characterization of circulating tumour cells in breast cancer patients
por: Nadal, Rosa, et al.
Publicado: (2012)

High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients
por: Cañadas, Israel, et al.
Publicado: (2014)

Deformation change between $^{184m}$Au and $^{184g}$Au
por: Roussière, B, et al.
Publicado: (1998)

Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte
por: Cicchini, Carla, et al.
Publicado: (2015)

Hepatocyte growth factor/MET in cancer progression and biomarker discovery
por: Matsumoto, Kunio, et al.
Publicado: (2017)

184th Session of the Council
por: Bennett, Sophia Elizabeth
Publicado: (2017)

Memorandum: PS184 experiment
por: Garreta, D
Publicado: (1982)

ROS1 copy number alterations are frequent in non-small cell lung cancer
por: Clavé, Sergi, et al.
Publicado: (2016)

Transitions électromagnétiques observées dans les désintegrations du mercure-184 et du platine-184
por: Caillau, M, et al.
Publicado: (1973)

Determination of nuclear moments of $^{184g,184m}$Au using high resolution RIS at ISOLDE
por: Pinard, J, et al.
Publicado: (1997)

Inhibition of JK184-Induced Cytoprotective Autophagy Potentiates JK184 Antitumor Effects in Breast Cancer
por: Xi, Xiaoya, et al.
Publicado: (2020)

Immunohistochemical and Ultrastructural Analyses of Cytoplasmic Blood Plasma Inclusions of Rat Hepatocytes
por: Tochitani, Tomoaki, et al.
Publicado: (2011)

Immunohistochemical expression of the hepatocyte growth factor in chromophobe renal cell carcinoma
por: Erlmeier, Maximilian, et al.
Publicado: (2023)

Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients
por: Montagut, C, et al.
Publicado: (2010)

P02.184. Abstract withdrawn
Publicado: (2012)

Expression of microRNA-184 in glioma
por: Wu, Xiao-Ben, et al.
Publicado: (2018)

Health Tract, No. 184: Kindness Rewarded
Publicado: (1865)

Health Tract, No. 184: Kindness Rewarded
Publicado: (1864)

Shape coexistence studied in ${}^{\mathrm{182,184}}$Hg via the β decay of ${}^{\mathrm{182,184}}$Tl
por: Rapisarda, E, et al.
Publicado: (2017)

Transmembrane protein 184B (TMEM184B) promotes expression of synaptic gene networks in the mouse hippocampus
por: Wright, Elizabeth B., et al.
Publicado: (2023)

c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesions
por: Halliday, Grant, et al.
Publicado: (2022)

Hepatocyte Growth Factor/c-Met Signaling Is Required for β-Cell Regeneration
por: Alvarez-Perez, Juan Carlos, et al.
Publicado: (2014)

Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases
por: Whang, Young Mi, et al.
Publicado: (2019)

MET Gene Copy Number Alterations and Expression of MET and Hepatocyte Growth Factor Are Potential Biomarkers in Angiosarcomas and Undifferentiated Pleomorphic Sarcomas
por: Schmitz, Katja, et al.
Publicado: (2015)

Impact of MET inhibition on small‐cell lung cancer cells showing aberrant activation of the hepatocyte growth factor/MET pathway
por: Taniguchi, Hirokazu, et al.
Publicado: (2017)

Chromatic transitions in the emergence of syntax networks
por: Corominas-Murtra, Bernat, et al.
Publicado: (2018)

Pancreatic Organoids for Regenerative Medicine and Cancer Research
por: Casamitjana, Joan, et al.
Publicado: (2022)

Memorandum: addendum to experiment PS184 at LEAR
por: Garreta, D
Publicado: (1982)

$\alpha$-decay study of $^{182,184}$Tl
por: Van Beveren, C, et al.
Publicado: (2016)

Oral Presentations O1 - O184
Publicado: (2005)

Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma
por: Rojo, Federico, et al.
Publicado: (2016)

Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros
Publicado: (1995)

The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatment
por: Parikh, Rahul A, et al.
Publicado: (2014)

Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors
por: Smyth, Elizabeth C, et al.
Publicado: (2014)

Functional and therapeutic relevance of hepatocyte growth factor/c‐MET signaling in synovial sarcoma
por: Imura, Yoshinori, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ec1raajcr94cblp1ra7d2lio93